LILRB1 and systemic lupus erythematosus: We found that, in SLE patients, ILT4 ligation (alone or in combination with anti-ILT2 mAb) conferred the ability to inhibit PBMC proliferation on moDC, which was not observed in healthy controls (Figure 5).